Tower Research Capital (TRC)’s Spruce Biosciences, Inc. Common Stock SPRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,697
| Closed | -$1.36K | – | 5664 |
|
|
2025
Q1 | $1.36K | Sell |
4,697
-64
| -1% | -$19 | ﹤0.01% | 4724 |
|
|
2024
Q4 | $2K | Buy |
4,761
+111
| +2% | +$47 | ﹤0.01% | 4927 |
|
|
2024
Q3 | $2.21K | Sell |
4,650
-28,437
| -86% | -$13.5K | ﹤0.01% | 5032 |
|
|
2024
Q2 | $17.1K | Buy |
33,087
+21,660
| +190% | +$11.2K | ﹤0.01% | 3845 |
|
|
2024
Q1 | $8.98K | Buy |
+11,427
| New | +$8.98K | ﹤0.01% | 3921 |
|
|
2023
Q4 | – | Sell |
-4,356
| Closed | -$9.85K | – | 6222 |
|
|
2023
Q3 | $9.85K | Buy |
4,356
+1,998
| +85% | +$4.52K | ﹤0.01% | 4175 |
|
|
2023
Q2 | $5.07K | Sell |
2,358
-1,522
| -39% | -$3.27K | ﹤0.01% | 4843 |
|
|
2023
Q1 | $9K | Sell |
3,880
-7,046
| -64% | -$16.3K | ﹤0.01% | 4562 |
|
|
2022
Q4 | $12K | Buy |
10,926
+3,601
| +49% | +$3.96K | ﹤0.01% | 3769 |
|
|
2022
Q3 | $10K | Buy |
7,325
+4,302
| +142% | +$5.87K | ﹤0.01% | 4588 |
|
|
2022
Q2 | $5K | Sell |
3,023
-2,319
| -43% | -$3.84K | ﹤0.01% | 5119 |
|
|
2022
Q1 | $11K | Buy |
5,342
+394
| +8% | +$811 | ﹤0.01% | 4225 |
|
|
2021
Q4 | $22K | Buy |
4,948
+1,687
| +52% | +$7.5K | ﹤0.01% | 3577 |
|
|
2021
Q3 | $20K | Buy |
3,261
+2,328
| +250% | +$14.3K | ﹤0.01% | 3732 |
|
|
2021
Q2 | $10K | Buy |
933
+248
| +36% | +$2.66K | ﹤0.01% | 4408 |
|
|
2021
Q1 | $11K | Buy |
685
+257
| +60% | +$4.13K | ﹤0.01% | 4326 |
|
|
2020
Q4 | $10K | Buy |
+428
| New | +$10K | ﹤0.01% | 4331 |
|